Maddison Davis
Family · Greenville, TXNPI 1912598772
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $23.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$567
- Novartis$413
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$398
- E.r. Squibb & Sons, L.L.C.$358
- Pfizer$357
- Medtronic$322
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,237100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 29 | $567 |
| Novartis | 16 | $413 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 22 | $398 |
| E.r. Squibb & Sons, L.L.C. | 16 | $358 |
| Pfizer | 21 | $357 |
| Medtronic | 8 | $322 |
| Abiomed | 3 | $297 |
| AstraZeneca | 7 | $194 |
| Johnson & Johnson | 10 | $177 |
| Cvrx, Inc. | 3 | $175 |
| Amgen | 11 | $174 |
| Scpharmaceuticals Inc. | 6 | $111 |
| Heartflow, Inc. | 2 | $93 |
| Boehringer Ingelheim | 4 | $86 |
| Boston Scientific | 3 | $81 |
| Surmodics, Inc. | 2 | $75 |
| Cleerly, Inc. | 1 | $64 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $37 |
| Bayer | 1 | $30 |
| GSK | 1 | $26 |
| Lexicon Pharmaceuticals, Inc. | 1 | $25 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
| ZOLL Respicardia, Inc. | 1 | $23 |
| Stryker | 1 | $21 |
| Contego Medical, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$270
- COREVALVE EVOLUT R$155
- LEQVIO$139
- CAMZYOS$133
- Barostim Neo System$121
How this compares
$4,237 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 62 | $613 |
Paid to pharmacies, not to this prescriber.
Other family in Greenville
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.